Association Between Arterial Wall Uptake of Fluorodeoxyglucose on PET Imaging and sRAGE
Arteriosclerosis is a dynamic inflammatory disorder. Recently, FDG-PET CT is emerging diagnostic tool of non-invasive technique to detect vulnerable atherosclerotic plaque. And there are arising evidence that sRAGE(soluble Receptor for Advanced glycation End Product) is correlated with metabolic risk. So the investigators will investigate association between sRAGE and FDG-PET uptake in large artery in healthy patient.
SUV and TBR Levels in FDG PET
|Study Design:||Observational Model: Case Control
Time Perspective: Cross-Sectional
|Official Title:||Association Between Arterial Wall Uptake of Fluorodeoxyglucose on PET Imaging and sRAGE|
|Study Start Date:||January 2009|
|Study Completion Date:||November 2010|
|Primary Completion Date:||August 2010 (Final data collection date for primary outcome measure)|
Type 2 DM, Healthy control
Type 2 DM patients are treating in the Diabetic Clinic of Korea university Guro hospital, and their age- and sex-matched healthy controls are underwent a routine health checkup at Korea university Guro hospital.
|Type 2 DM, Heatlhy control|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01021514
|Principal Investigator:||Kyoungmook Choi, MD, PhD||Korea University Guro Hospital|